Development and validation of new diagnostic criteria for atopic dermatitis in children of China

医学 特应性皮炎 流行病学 队列 儿科 皮肤病科 队列研究 回顾性队列研究 临床诊断 内科学
作者
Ruhong Cheng,Hai Zhang,Wenkai Zong,Jianping Tang,Xiuping Han,Li Zhang,X. Zhang,Heng Gu,Yaqing Shu,Ge Peng,Linting Huang,Qiang Liu,Xing Gao,Yong Guo,Zhirong Yao
出处
期刊:Journal of The European Academy of Dermatology and Venereology [Wiley]
卷期号:34 (3): 542-548 被引量:23
标识
DOI:10.1111/jdv.15979
摘要

Abstract Background In previous epidemiological study, the prevalence of atopic dermatitis ( AD ) was 12.94% among children aged 1–7 years by clinical diagnosis, whereas that was 4.76% and 3.51% using U.K., and Hanifin and Rajka diagnostic criteria. Objective We aimed to propose new diagnostic criteria for children and evaluate its efficiency in different populations. Methods We screened atopic features and analysed their correlation with AD using data from a previous study. A new set of diagnostic criteria for children in China was proposed and validated in 1031 children in outpatient clinics and 538 children in a birth cohort survey. Clinical diagnosis and atopic feature evaluation were performed face to face by dermatologists specialized in AD . Three criteria were compared for diagnostic efficiency using the clinical diagnosis as the reference. Results The new diagnostic criteria for children were based on (i) pruritus; (ii) ‘typical morphology and distribution’ or ‘atypical morphology and distribution with xerosis’; and (iii) a chronic or chronically relapsing course. Compared to classical diagnostic criteria, the sensitivity of the new diagnostic criteria was significantly higher in the epidemiological survey and the clinical setting, especially obvious among mild and moderate AD . In the birth cohort, the new criteria showed similar sensitivity and specificity. Conclusion The new criteria for children yielded higher sensitivity for the diagnosis of AD in the epidemiological survey and clinical setting, particularly for mild and moderate AD . Among the birth cohort with a complete medical history, three criteria showed similar sensitivity and specificity.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
1秒前
1秒前
2秒前
小二郎应助李家静采纳,获得10
2秒前
冉冉完成签到,获得积分20
2秒前
4秒前
4秒前
dddd完成签到,获得积分20
5秒前
冉冉发布了新的文献求助10
5秒前
ggg发布了新的文献求助10
6秒前
Oreki发布了新的文献求助10
7秒前
9秒前
谢大喵发布了新的文献求助30
10秒前
奋斗小蜜蜂完成签到,获得积分10
10秒前
chenzihao发布了新的文献求助10
10秒前
11秒前
11秒前
秀丽雁风完成签到,获得积分20
11秒前
chuanxue完成签到,获得积分10
12秒前
12秒前
13秒前
14秒前
爱喝水发布了新的文献求助10
14秒前
完美世界应助522采纳,获得50
16秒前
sibia完成签到,获得积分10
16秒前
大个应助简7采纳,获得30
17秒前
柴胡发布了新的文献求助10
17秒前
17秒前
上官若男应助hd采纳,获得10
18秒前
chuanxue发布了新的文献求助30
18秒前
whandzxl发布了新的文献求助10
18秒前
19秒前
19秒前
量子星尘发布了新的文献求助30
19秒前
慕青应助爱喝水采纳,获得10
20秒前
21秒前
wxx完成签到,获得积分10
22秒前
23秒前
Wang完成签到,获得积分10
23秒前
chenzihao完成签到,获得积分20
24秒前
高分求助中
Comprehensive Toxicology Fourth Edition 24000
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Pipeline and riser loss of containment 2001 - 2020 (PARLOC 2020) 1000
World Nuclear Fuel Report: Global Scenarios for Demand and Supply Availability 2025-2040 800
Handbook of Social and Emotional Learning 800
Risankizumab Versus Ustekinumab For Patients with Moderate to Severe Crohn's Disease: Results from the Phase 3B SEQUENCE Study 600
Lloyd's Register of Shipping's Approach to the Control of Incidents of Brittle Fracture in Ship Structures 500
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 内科学 生物化学 物理 计算机科学 纳米技术 遗传学 基因 复合材料 化学工程 物理化学 病理 催化作用 免疫学 量子力学
热门帖子
关注 科研通微信公众号,转发送积分 5144545
求助须知:如何正确求助?哪些是违规求助? 4342237
关于积分的说明 13522560
捐赠科研通 4182757
什么是DOI,文献DOI怎么找? 2293639
邀请新用户注册赠送积分活动 1294207
关于科研通互助平台的介绍 1236955